Related Experiment Video
Updated: Jun 6, 2026

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
Published on: November 28, 2025
[Risk groups in differentiated thyroid carcinomas]
Jesús Herránz González-Botas1, Carlos Vázquez Barro, José Martínez Vidal
1Servicio de Otorrinolaringología, Complejo Hospitalario Universitarios de A Coruña, La Coruña, España. jesus.herranz.gonzalez.botas@sergas.es
Well-differentiated thyroid carcinoma (WDTC) is common, with most patients having a low risk of recurrence and excellent long-term survival. Risk factor evaluation helps personalize treatment, avoiding unnecessary aggressive therapies.
Area of Science:
- Endocrinology
- Oncology
- Surgical Pathology
Context:
- Well-differentiated thyroid carcinoma (WDTC) accounts for 80% of thyroid malignancies.
- Despite increasing incidence, survival rates for WDTC remain stable at over 95% at 20 years for 80% of cases.
- Accurate prognostic factor evaluation is crucial for stratifying patients into high- or low-risk groups.
Purpose:
- To review the incidence of malignant thyroid neoplasms using TNM, GAMES, and MACIS staging systems.
- To analyze the rate of post-surgical complications in thyroid cancer patients.
- To assess the distribution of risk groups in WDTC based on established staging systems.
Summary:
- Malignant neoplasms constitute 28.8% of thyroidectomies, with 88% being WDTC.
- Approximately 80% of WDTC patients fall into the low-risk category across all three staging systems.
- Low rates of permanent complications were observed: 1.2% for recurrent nerve palsy and 2.7% for hypocalcemia.
Impact:
- The study confirms that the majority of WDTC patients are low-risk with a favorable prognosis.
- Risk stratification aids in tailoring treatment strategies, preventing overtreatment in low-risk individuals.
- Personalized treatment approaches can minimize surgical complications and improve patient outcomes.
More Related Videos
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
Related Concept Videos
Graves' Disease I: Introduction
Hyperthyroidism II: Pathophysiology
Graves Disease II: Pathophysiology
Goiter
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Hyperthyroidism I: Introduction